Delivery Order V797D50597-15B41224F00000010
Award Date
11/15/23
Potential Completion Date
11/17/23
Potential Value
$25K
Federal Agency
Federal Medical Center Rochester
Awardee
Roche Diabetes Care Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order from the Department of Justice Bureau of Prisons Federal Medical Center Rochester is valued at $17,036.56 for Roche Diagnostics reagents to be provided by Roche Diabetes Care Inc. under its GSA Schedule contract for invitro diagnostics, reagents, and tests. The order has a period of performance from October 25-27, 2023 for products to be delivered to the Castleton, Indiana location. Roche Diabetes Care Inc. will serve as the prime contractor, supplying medical testing...
The Department of Justice Bureau of Prisons Federal Medical Center in Rochester, Minnesota awarded a $17,378 delivery order against Roche Diabetes Care Inc.'s GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. Roche Diabetes Care, Inc. will provide diagnostic products and services from its Castleton, Indiana division to support the Bureau of Prisons' medical programs. As a firm fixed price order, Roche will deliver the requested goods and services at the established GSA...
This is a firm fixed-price delivery order awarded by the Department of Justice Bureau of Prisons Federal Medical Center Rochester to Roche Diabetes Care Inc. under the company's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The order, valued at $105,297.54, is for Roche's lab supplies to support medical operations at the Bureau of Prisons facility. Roche Diabetes Care Inc. is a manufacturer of diabetes management...
The Department of Justice Bureau of Prisons Federal Medical Center in Rochester, Minnesota awarded a $19,326 delivery order contract to Roche Diabetes Care Inc. for B5 reagents. The contract was awarded against Roche's GSA Schedule 65-VII for invitro diagnostics, reagents, and tests. Performance will take place in Castleton, Indiana from June 21-30, 2023. The firm fixed price contract supports the Bureau of Prisons' medical programs by providing diagnostic test materials from Roche, a leading...
This is a $89,599.14 firm fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Medical Center Rochester to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for laboratory services and reagents. The award is not set aside and will be performed in Castleton, Indiana. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche holds...
Roche Diagnostics Corporation was awarded a $67,028.84 firm fixed price delivery order against its General Services Administration (GSA) Multiple Award Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The delivery order from the Department of Justice Bureau of Prisons Federal Medical Center Rochester is for fiscal year 2024 B5 Roche MO service and reagents to be provided through September 30, 2024. The place of performance is Castleton, Indiana. No set-aside designation was...
This is a delivery order awarded by the Department of Justice Bureau of Prisons Federal Medical Center Rochester to Roche Diagnostics Corporation for $74,851.82 to provide service and reagents for Roche Medical Laboratory equipment. The contract is a Firm Fixed Price instrument under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule. It does not have a set-aside designation. The contract will run from April 1, 2024 to September 30, 2024. Roche...
This federal contract award is for FY24 B5 ROCHE MO. SERVICE AND REAGENTS, with a potential value of $29,418.54. The contract was awarded on March 1, 2024, to the prime contractor Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, and has a completion date of April 30, 2024. The contract is a Delivery Order placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III), with a Firm Fixed Price pricing type. The...
This is a firm fixed-price delivery order awarded by the Federal Medical Center Rochester, a civilian agency, to Roche Diagnostics Corporation under GSA Schedule Contract V797P7347A. The order is for FY24 B5 ROCHE MO. SERVICE AND REAGENTS with an ultimate completion date of February 14, 2025 and a ceiling value of $54,477.58. The contract provides critical analyzers, laboratory equipment, reagents, and associated products and services to support healthcare operations at the agency. Roche...
This is a delivery order issued under a General Services Administration (GSA) Multiple Award Schedule contract held by Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $57,018.17 fixed-price award is for FY24 B5 service and reagents to support medical laboratory operations at the Federal Medical Center in Rochester, IN. The order was placed by the Department of Veterans Affairs and does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit...